RSV Fusion F Glycoprotein
Deadly to newborn babies, the Human Respiratory Syncytial Virus (HSV) is a major cause of lower respiratory tract infection. Dynamic structural changes in the Fusion F Glycoprotein reveal and hide binding sites, making targets of new therapies difficult to identify. Explore RSV Fusion F Glycoprotein-3RRR and learn more about its Postfusion 3D structure.
CRISPR-Cpf1 Bound to Guide RNA and Target DNA
Explore the internal secondary structures of CRISPR-Cpf1 with this 3D Printed Protein Model and free Augemented Reality App.
Protein Description This cytotoxic drug utilizes Molecular Templates an innovative Engineered Toxic Bodies (ETBs) drug delivery platform to trigger cell death. MT-3724 is being developed for the treatment of non-Hodgkin’s Lymphoma and harnesses the immunotherapy power of antibody receptor-specific targeting combined, a bacterial process for cell invasion that infects cancer cells with ribosomal inhibitors that […]